AbbVie Says Recent Antitrust Ruling Irrelevant In Humira Case
By Matthew Perlman · May 20, 2020, 5:28 PM EDT
AbbVie Inc. has told an Illinois federal court that a recent ruling in a case involving speech recognition technology is not relevant whatsoever to Humira buyers' allegations that the pharmaceutical giant...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login